首页> 外国专利> NANOMETER TARGETED DRUG FOR MAGNETO-THERMOTHERAPY OF MALIGNANT TUMORS

NANOMETER TARGETED DRUG FOR MAGNETO-THERMOTHERAPY OF MALIGNANT TUMORS

机译:纳米靶向药物治疗恶性肿瘤的磁疗

摘要

The present invention relates to a targeted magnetic nanoparticle drug and the preparation method thereof. The targeted magnetic nanoparticle drug comprises an effector molecule and a guidance molecule in a weight ratio of 1 : 0.0001-0.20. The aforesaid effector molecule is a magnetic particle, with a particle size of not more than 1000 nm and a specific adsorption rate (SAR) of 10-7000 W/gFe. The aforesaid guidance molecule comprises an antibody, a ligand or a magnetic particle. The particle size of the aforesaid targeted drug is 2-1000 nm. The targeted magnetic nanoparticle drug is prepared by coupling a magnetic particle and a guidance molecule in a weight ratio of 1 : 0.0001-0.20 in water, organic or inorganic substance or the mixed solution thereof. The resultant targeted magnetic nanoparticle drug can realize targeted magnetic hyperthermia treatment and targeted magnetic thermoablation treatment and prevention on the tumors, and effectively kill the cancer cells, and cure the malignant tumors.
机译:本发明涉及一种靶向磁性纳米颗粒药物及其制备方法。靶向磁性纳米颗粒药物包含重量比为1:0.0001-0.20的效应分子和引导分子。上述效应分子是磁性颗粒,其粒径不大于1000nm,比吸附率(SAR)为10-7000W / gFe。上述指导分子包含抗体,配体或磁性颗粒。上述靶向药物的粒径为2-1000nm。通过在水中,有机或无机物质或其混合溶液中以1:0.0001-0.20的重量比偶联磁性颗粒和引导分子来制备目标磁性纳米颗粒药物。所得的靶向磁性纳米颗粒药物可以实现对肿瘤的靶向磁热疗和靶向磁热消融治疗及预防,有效杀死癌细胞,治愈恶性肿瘤。

著录项

  • 公开/公告号EP1952825A1

    专利类型

  • 公开/公告日2008-08-06

    原文格式PDF

  • 申请/专利权人 ZHU HONG;

    申请/专利号EP20060805000

  • 发明设计人 ZHU HONG;

    申请日2006-10-20

  • 分类号A61K47/48;A61K33/26;A61K9/14;A61K39/395;A61P35;A61K9/08;

  • 国家 EP

  • 入库时间 2022-08-21 19:55:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号